Intrexon Corporation (XON) was a big mover last session, with shares rising over 8% on the day. The move came on solid volume too, with far more shares changing hands than in a normal session. This reverses the recent trend of Intrexon, as the stock is now down over 14% in the past one-month time frame.
This biotechnology company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Intrexon currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the Healthcare sector are Covance Inc. (CVD), Air Methods Corp. (AIRM) and Charles River Laboratories International, Inc. (CRL). All these stocks carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment